Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1992 | 09-1992 | 06-1992 | 03-1992 | 12-1991 | |
| Sales | 747 | 632 | 672 | 600 | 682 |
| Cost of Goods | 687 | 672 | 659 | 685 | 635 |
| Gross Profit | 60 | -40 | -37 | -85 | 97 |
| Operating Expenses | 1,047 | 944 | 959 | 962 | 891 |
| Operating Income | -300 | -312 | -287 | -362 | -209 |
| Interest Expense | 17 | 19 | 19 | 25 | 13 |
| Other Income | 9 | 12 | -112 | 47 | -132 |
| Pre-tax Income | -309 | -318 | -418 | -339 | -354 |
| Income Tax | 1 | 0 | -69 | 5 | 0 |
| Net Income Continuous | -243 | -249 | -250 | -266 | -247 |
| Net Income Discontinuous | -1,998,000 | -1,997,982 | 63 | -1,997,928 | -1,997,955 |
| Net Income | $-243 | $-231 | $-187 | $-194 | $-202 |
| EPS Basic Total Ops | -0.05 | -0.04 | -0.04 | -0.04 | -0.04 |
| EPS Basic Continuous Ops | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 |
| EPS Basic Discontinuous Ops | -411.11 | -381.15 | 0.01 | -384.51 | -387.28 |
| EPS Diluted Total Ops | -0.05 | -0.04 | -0.03 | -0.04 | -0.04 |
| EPS Diluted Continuous Ops | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 |
| EPS Diluted Discontinuous Ops | -411.11 | -381.15 | 0.01 | -384.51 | -387.28 |
| EBITDA(a) | $-300 | $-312 | $-287 | $-362 | $-209 |